Clinical Trials Browser

Phase 2/3 × Recruiting × NETWORK × Clear all

NCT04093167 2026-03-11

Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

Phase 2/3 Recruiting

Lung Neoplasms

NCT03851445 2025-12-05

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

10,000 enrolled

Previously Treated Non-Small Cell Lung Cancer